Risk alleles in PNPLA3 additively conferred risk of hepatic fibrosis in participants with NAFLD at baseline, regardless of muscle mass or other metabolic risk factors. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.